2 Biotech Stocks That Are Screaming Buys This Month

They won't remain southbound forever. CRISPR Therapeutics (CRSP 3.22%) and Moderna (MRNA 2.57%) have much in common. They're both innovative biotechs working in relatively newer niches of this booming industry. However, they've moved in the wrong direction this year. CRISPR's shares are down by 27% year to date, and Moderna's are down by 41%. Regardless of their performances so far in 2024, both stocks are worth investing in this month. Read on to find out why. 1. CRISPR Therapeutics CRISPR Therapeutics rec ...